Skip to main content
SpringerLink
Log in

Epidemiology of Behçet Syndrome and Regional Differences in Disease Expression

  • Chapter
  • First Online:
Behçet Syndrome

Abstract

Behçet syndrome (BS) is more prevalent along the ancient trading route known as the “Silk Road,” extending from the Mediterranean to the countries in the Far East, where the prevalence of HLA-B5 (51) is relatively more frequent in the healthy population. This suggests that the possible causative agent(s), including genetic factors such as HLA-B51, might have had spread along this route. Seven cross-sectional and population-based field studies showed that the prevalence of BS was between 19 and 421 among 100,000 adolescent/adult population in Turkey. The lower three frequencies (19, 20, and 80/105) come from Thrace, the European part. The disease is less common in Western Europe, the USA, and in the rest of the world but perhaps not as rare as it had previously been thought. A recent study showed that BS was as frequent (7.1/105) as other vasculitic diseases – 9/105 for the combination of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg–Strauss syndrome – in a suburb of Paris, France. This chapter focuses on the epidemiological features of the field surveys of BS in Turkey and the rest of the globe as well as regional differences in some of the clinical and laboratory features. Gastrointestinal disease is frequent in patients from the Far East (especially Japan), while it is rather infrequent among those from Turkey. Moreover, a high frequency of both pathergy test positivity and being a carrier of HLA-B5 (51) is observed in patients from Japan and the Mediterranean countries, in contrast to the patients from the UK and the USA.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Verity DH, Marr JE, Ohno S, et al. Behçet’s disease, the silk road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999;54:213–20.

    Article  CAS  PubMed  Google Scholar 

  2. Demirhindi O, Yazici H, Binyildiz P, et al. Silivri Fener koyu ve yoresinde Behçet hastaligi sikligi ve bu hastaligin toplum icinde taranabilmesinde kullanabilecek bir yontem. Cerrahpasa Tip Fak Derg. 1981;12:509–14. (in Turkish).

    Google Scholar 

  3. Yurdakul S, Gunaydin I, Tuzun Y, et al. The prevalence of Behçet’s syndrome in a rural area in northern Turkey. J Rheumatol. 1988;15:820–2.

    CAS  PubMed  Google Scholar 

  4. Idil A, Gurler A, Boyvat A, et al. The prevalence of Behçet’s disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic Epidemiol. 2001;9:325–31.

    Article  Google Scholar 

  5. Azizlerli G, Kose AA, Sarica R, et al. Prevalence of Behçet’s disease in Istanbul, Turkey. Int J Dermatol. 2003;42:803–6.

    Article  PubMed  Google Scholar 

  6. Cakir N, Dervis E, Benian O, et al. Prevalence of Behçet’s disease in rural western Turkey: a preliminary report. Clin Exp Rheumatol. 2004;22(4 Suppl 34):S53–5.

    CAS  PubMed  Google Scholar 

  7. Cakır N, Pamuk ON, Derviş E, et al. The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int. 2012;32:895–908.

    Article  PubMed  Google Scholar 

  8. Colgecen E, Ozyurt K, Ferahbas A, et al. The prevalence of Behçet’s disease in a city in Central Anatolia in Turkey. Int J Dermatol. 2015;54:286–9.

    Article  PubMed  Google Scholar 

  9. O’Duffy JD. Suggested criteria for diagnosis of Behçet’s disease. J Rheumatol. 1974;1(Suppl 1):18, Abstract 32.

    Google Scholar 

  10. International Study Group for Behçet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335:1078–80.

    Google Scholar 

  11. Ozen S, Karaaslan Y, Ozdemir O, et al. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol. 1998;25:2445–9.

    CAS  PubMed  Google Scholar 

  12. Yazici H, Akokan G, Yalgin B, Muftuoglu A. A high prevalence of HLA-B5 in Behçet’s disease. Clin Exp Immunol. 1977;30:259–61.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Seyahi E, Tahir Turanli E, Mangan MS, Celikyapi G, Oktay V, Cevirgen D, et al. The prevalence of Behçet’s syndrome and familial Mediterranean fever HLA-B51 and MEVF gene mutations among ethnic Armenians living in Istanbul, Turkey. Clin Exp Rheumatol. 2010;28(4 Suppl 60):S67–75.

    PubMed  Google Scholar 

  14. Al-Rawi ZS, Neda AH. Prevalence of Behçet’s disease among Iraqis. Adv Exp Med Biol. 2003;528:37–41.

    Article  CAS  PubMed  Google Scholar 

  15. Davatchi F, Jamshidi AR, Banihashemi AT, et al. WHO-ILAR COPCORD study (stage 1, urban study) in Iran. J Rheumatol. 2008;35:1384–90.

    PubMed  Google Scholar 

  16. Moghimi N, Davatchi F, Rahimi E, Saidi A, Rashadmanesh N, Moghimi S, et al. WHO-ILAR COPCORD study (stage 1, urban study) in Sanandaj, Iran. Clin Rheumatol. 2015;34:535–43.

    Article  PubMed  Google Scholar 

  17. Al-Dalaan A, Al Ballaa S, Al Sukati M, Mousa M, Bahabri S, Biyari T. The prevalence of Behçet’s disease in Al Qassim region of Saudi Arabia. In: Hamza M, editor. Behçet’s disease. Tunis, Tunisia: Pub Adhoua; 1997. p. 170–2.

    Google Scholar 

  18. Li R, Sun J, Ren LM, et al. Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology (Oxford). 2012;51:721–9.

    Article  Google Scholar 

  19. Chaaya M, Slim ZN, Habib RR, et al. High burden of rheumatic diseases in Lebanon: a COPCORD study. Int J Rheum Dis. 2012;15:136–43.

    Article  PubMed  Google Scholar 

  20. Maldini C, Druce K, Basu N, LaValley MP, Mahr A. Exploring the variability in Behçet’s disease prevalence: a meta-analytical approach. Rheumatology (Oxford). 2018;57:185–95.

    Article  Google Scholar 

  21. Hatemi G, Esatoglu SN, Yurdakul S. Considerations in designing and interpreting prevalence studies for Behçet’s syndrome. Pol Arch Intern Med. 2018;128:148–9.

    PubMed  Google Scholar 

  22. Krause I, Yankevich A, Fraser A, Rosner I, Mader R, Zisman D, et al. Prevalence and clinical aspects of Behçet’s disease in the north of Israel. Clin Rheumatol. 2007;26:555–60.

    Article  PubMed  Google Scholar 

  23. Jaber L, Milo G, Halpern GJ, et al. Prevalence of Behçet’s disease in an Arab community in Israel. Ann Rheum Dis. 2002;61:365–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Klein P, Weinberger A, Altmann VJ, Halabi S, Fachereldeen S, Krause I. Prevalence of Behcet’s disease among adult patients consulting three major clinics in a Druze town in Israel. Clin Rheumatol. 2010;29:1163–6.

    Article  PubMed  Google Scholar 

  25. Yamamoto S, Toyokawa H, Matsubara J, et al. A nation wide survey of Behçet’s disease in Japan. Jpn J Ophthalmol. 1974;18:282–90.

    Google Scholar 

  26. Shimizu T, Ehrlich GE, Inaba G, Hayashi K. Behçet’s disease (Behçet’s syndrome). Semin Arthritis Rheum. 1979;8:223–60.

    Article  CAS  PubMed  Google Scholar 

  27. Nakae K, Masaki F, Hashimoto T, Inaba G, Mochizuki M, Sakane T. Recent epidemiological features of Behçet’s disease in Japan. In: Wechsler B, Godeau P, editors. Behçet’s disease. Amsterdam: Excerpta Medica; 1993. p. 145–51.

    Google Scholar 

  28. Iwata D, Namba K, Kitaichi N, et al. Recent clinical features of Behçet’s disease in Hokkaido, Japan. Clin Exp Rheumatol. 2004;22(Suppl 34):S-48.

    Google Scholar 

  29. Mishima S, Masuda K, İzawa Y, et al. Behçet’s disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc. 1979;76:225–79.

    Google Scholar 

  30. Goto H, Mochizuki M, Yamaki K, et al. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol. 2007;51:41–4.

    Article  PubMed  Google Scholar 

  31. Bang D, Yoon KH, Chung HG, Choi EH, Lee ES, Lee S. Epidemiological and clinical features of Behçet’s disease in Korea. Yonsei Med J. 1997;38:428–36.

    Article  CAS  PubMed  Google Scholar 

  32. Bang D, Lee JH, Lee ES, Lee S, Choi JS, Kim YK, et al. Epidemiologic and clinical survey of Behçet’s disease in Korea: the first multicenter study. J Korean Med Sci. 2001;16:615–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Kim JN, Kwak SG, Choe JY, Kim SK. The prevalence of Behçet’s disease in Korea: data from Health Insurance Review and Assessment Service from 2011 to 2015. Clin Exp Rheumatol. 2017;35 Suppl 108(6):38–42.

    PubMed  Google Scholar 

  34. Chang NC. Rheumatic diseases in China. J Rheumatol. 1983;10(Suppl 10):41–4.

    CAS  Google Scholar 

  35. Kaneko F, Nakamura K, Sato M, Tojo M, Zheng X, Zhang JZ. Epidemiology of Behçet’s disease in Asian countries and Japan. Adv Exp Med Biol. 2003;528:25–9.

    Article  PubMed  Google Scholar 

  36. Mok CC, Cheung TC, Ho CT, et al. Behçet’s disease in southern Chinese patients. J Rheumatol. 2002;29:1689–93.

    PubMed  Google Scholar 

  37. Mousa AR, Marafie AA, Rifai KM, Dajani AI, Mukhtar MM. Behçet’s disease in Kuwait, Arabia: a report of 29 cases and a review. Scand J Rheumatol. 1986;15:310–32.

    Article  CAS  PubMed  Google Scholar 

  38. Chen Y-C, Chang H-W. Clinical characteristics of Behçet’s disease in southern Taiwan. J Microbiol Immunol Infect. 2001;34:207–10.

    CAS  PubMed  Google Scholar 

  39. Yu KH, See LC, Kuo CF, Chou IJ, Chou MJ. Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan. Arthritis Care Res (Hoboken). 2013;65:244–50.

    Article  Google Scholar 

  40. See LC, Kuo CF, Chou IJ, et al. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study. Semin Arthritis Rheum. 2013;43:381–6.

    Article  PubMed  Google Scholar 

  41. Madanat WY, Alawneh KM, Smadi MM, et al. The prevalence of Behçet’s disease in the north of Jordan: a hospital-based epidemiological survey. Clin Exp Rheumatol. 2017;35 Suppl 108(6):51–4.

    PubMed  Google Scholar 

  42. Jankowski J, Crombie I, Jankowski R. Behçet’s syndrome in Scotland. Postgrad Med J. 1992;68:566–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Chamberlain MA. Behçet’s syndrome in 32 patients in Yorkshire. Ann Rheum Dis. 1977;36:491–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Kanecki K, Nitsch-Osuch A, Goryński P, Tarka P, Kutera A, Tyszko P. Behçet disease: a rare systemic vasculitis in Poland. Pol Arch Intern Med. 2017;127:652–6.

    PubMed  Google Scholar 

  45. Ek L, Hedfors E. Behçet’s disease: a review and a report of 12 cases from Sweden. Acta Derm Venereol. 1993;73:251–4.

    CAS  PubMed  Google Scholar 

  46. Mohammad A, Mandl T, Sturfelt G, Segelmark M. Incidence, prevalence and clinical characteristics of Behcet’s disease in southern Sweden. Rheumatology (Oxford). 2013;52:304–10.

    Article  Google Scholar 

  47. Crespo J, Ribeiro J, Jesus E, Moura A, Reis C, Porto A. Behçet’s disease: particular features at the central zone of Portugal. In: Wechsler B, Godeau P, editors. Behçet’s disease: international congress series 1037. Amsterdam: Exerpta Medica; 1993. p. 207–10.

    Google Scholar 

  48. Kappen JH, van Dijk EH, Baak-Dijkstra M, van Daele PL, Lam-Tse WK, van Hagen PM, van Laar JA. Behçet’s disease, hospital-based prevalence and manifestations in the Rotterdam area. Neth J Med. 2015;73:471–7.

    CAS  PubMed  Google Scholar 

  49. Salvarani C, Pipitone N, Catanoso MG, et al. Epidemiology and clinical course of Behçet’s disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum. 2007;57:171–8.

    Article  PubMed  Google Scholar 

  50. Olivieri I, Leccese P, Padula A, Nigro A, Palazzi C, Gilio M, D’Angelo S. High prevalence of Behçet’s disease in southern Italy. Clin Exp Rheumatol. 2013;31(3 Suppl 77):28–31.

    PubMed  Google Scholar 

  51. Cartella S, Filippini M, Tincani A, Airo P. Prevalence of Behçet’s disease in the province of Brescia in northern Italy. Clin Exp Rheumatol. 2014;32(4 Suppl 84):S176.

    PubMed  Google Scholar 

  52. Gonzalez-Gay MA, Garcia-Porrua C, Branas F, et al. Epidemiologic and clinical aspects of Behçet’s disease in a defined area of Northwestern Spain, 1988–1997. J Rheumatol. 2000;27:703–7.

    CAS  PubMed  Google Scholar 

  53. Graña J, Sánchez-Meizoso MO, Galdo F. Epidemiological aspects of Behçet’s disease in Galicia. J Rheumatol. 2001;28:2565–6.

    PubMed  Google Scholar 

  54. Sanchez Burson J, Grandal Y, Mendoza M, Montero R, Rejon E, Marenco JL. Clinical characteristics, HLA antigen and mortality in Behçet’s syndrome in Spain. In: Olivieri I, Salvarani C, Cantini F, editors. 8th international congress on Behçet’s disease: program and abstracts. Milan: Prex; 1998. p. 102.

    Google Scholar 

  55. Papoutsis NG, Abdel-Naser MB, Altenburg A, et al. Prevalence of Adamantiades-Behçet’s disease in Germany and the municipality of Berlin: results of a nationwide survey. Clin Exp Rheumatol. 2006;24(5 Suppl 42):S125.

    CAS  PubMed  Google Scholar 

  56. Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, et al. Population-based prevalence study of Behçet’s disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum. 2008;58:3951–9.

    Article  PubMed  Google Scholar 

  57. Mahr A, Guillevin L, Poissonnet M, Ayme S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg–Strauss syndrome in a French urban multiethnic population in 2000: a capture–recapture estimate. Arthritis Rheum. 2004;51:92–9.

    Article  PubMed  Google Scholar 

  58. Yazici H, Seyahi E, Yurdakul S. Behçet’s syndrome is not so rare: why do we need to know? Arthritis Rheum. 2008;58:3640–3.

    Article  PubMed  Google Scholar 

  59. B’chir Hamzaoui S, Harmel A, Bouslama K, Abdallah M, Ennafaa M, M’rad S, et al. La maladie de Behçet en Tunisie. Étude clinique de 519 cas [Behçet’s disease in Tunisia. Clinical study of 519 cases]. Rev Med Interne. 2006;27:742–50.

    Article  PubMed  Google Scholar 

  60. Houman MH, Neffati H, Braham A, Harzallah O, Khanfir M, Miled M, Hamzaoui K. Behçet’s disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients. Clin Exp Rheumatol. 2007;25(4 Suppl 45):S58–64.

    CAS  PubMed  Google Scholar 

  61. Benamour S, Zeroual B, Alaoui FZ. Joint manifestations in Behçet’s disease. A review of 340 cases. Rev Rhum Engl Ed. 1998;65:299–307.

    CAS  PubMed  Google Scholar 

  62. Taarit CB, Ben Turki S, Ben Maïz H. Rheumatologic manifestations of Behçet’s disease: report of 309 cases. Rev Med Interne. 2001;22(11):1049–55.

    Article  CAS  PubMed  Google Scholar 

  63. Assaad-Khalil SH, Kamel FA, Ismail EA. Starting a regional registry for patients with Behçet’s disease in North West Nile Delta region in Egypt. In: Hamza M, editor. Behçet’s disease. Tunis, Tunisia: Pub Adhoua; 1997. p. 173–6.

    Google Scholar 

  64. Dia D, Dieng MT, Sy Ndiaye T, Fall S, Ndongo S, Diallo M, Moreira Diop T, Labou A, Ndiaye B. Behçet’s disease in Dakar (Senegal): epidemiological and clinical features. Dakar Med. 2003;48:64–7.

    CAS  PubMed  Google Scholar 

  65. Ndiaye M, Sow AS, Valiollah A, et al. Behçet’s disease in black skin. A retrospective study of 50 cases in Dakar. J Dermatol Case Rep. 2015;9:98–102.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Poon W, Verity DH, Larkin GL, et al. Behçet’s disease in patients of West African and Afro-Caribbean origin. Br J Ophthalmol. 2003;87:876–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Liozon E, Roussin C, Puéchal X, et al. Behçet’s disease in East African patients may not be unusual and is an HLA-B51 negative condition: a case series from Mayotte (Comoros). Joint Bone Spine. 2011;78:166–70.

    Article  PubMed  Google Scholar 

  68. Ajose FO, Adelowo O, Oderinlo O. Clinical presentations of Behçet’s disease among Nigerians: a 4-year prospective study. Int J Dermatol. 2015;54:889–97.

    Article  CAS  PubMed  Google Scholar 

  69. Hirohata T, Kuratsune M, Nomura A, Jimi S. Prevalence of Behçet’s syndrome in Hawai. Hawaii Med J. 1975;34:244–6.

    CAS  PubMed  Google Scholar 

  70. O’Duffy JD. Summary of international symposium on Behçet’s disease. J Rheumatol. 1978;5:229–33.

    PubMed  Google Scholar 

  71. Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM. Epidemiology and clinical characteristics of Behçet’s disease in the US: a population-based study. Arthritis Rheum. 2009;61:600–4.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Yazici Y, Moses N. Clinical manifestations and ethnic background of patients with Behçet’s syndrome in a US cohort. Arthritis Rheum. 2007;56:S502.

    Google Scholar 

  73. Oliveira AC, Buosi AL, Dutra LA, de Souza AW. Behçet disease: clinical features and management in a Brazilian tertiary hospital. J Clin Rheumatol. 2011;17:416–20.

    Article  PubMed  Google Scholar 

  74. Sachetto Z, Mahayri N, Ferraz RH, Costallat LT, Bertolo MB. Behçet’s disease in Brazilian patients: demographic and clinical features. Rheumatol Int. 2012;32:2063–7.

    Article  PubMed  Google Scholar 

  75. Cooper DA, Penny R. Behçet’s syndrome: clinical, immunological and therapeutic evaluation of 17 patients. Aust NZ J Med. 1974;4:585–96.

    Article  CAS  Google Scholar 

  76. Hemminki K, Bermajo LJ, Forsti A. The balance between heritable and environmental aetiology of human disease. Nat Rev Genet. 2006;7:958–65.

    Article  CAS  PubMed  Google Scholar 

  77. Tanaka C, Matsuda T, Hayashi E, Imamura Y, Ozaki S. Clinical manifestations and course of 200 Japanese patients with Behçet’s disease. Adv Exp Med Biol. 2003;528:77–9.

    Article  CAS  PubMed  Google Scholar 

  78. Oshima Y, Shimizu T, Yokohari R, Matsumoto T, Kano K, Kagami T, Nagaya H. Clinical studies on Behçet’s syndrome. Ann Rheum Dis. 1963;22:36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Fukuda Y, Watanabe I. Pathological studies on intestinal Behçet’s (entero-Behçet’s) disease. In: Dilsen N, Konice M, Ovul C, editors. Behçet’s disease, proceedings of an international symposium on Behçet’s disease. Amsterdam: Excerpta Medica; 1979. p. 90–5.

    Google Scholar 

  80. Adeeb F, Ugwoke A, Stack AG, Fraser AD. Associations of HLA-B alleles with Behçet’s disease in Ireland. Clin Exp Rheumatol. 2017;35 Suppl 104:22–3.

    PubMed  Google Scholar 

  81. Yurdakul S, Tuzuner N, Yurdakul I, et al. Gastrointestinal involvement in Behçet’s syndrome: a controlled study. Ann Rheum Dis. 1996;55:208–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Hatemi I, Esatoglu SN, Hatemi G, Erzin Y, Yazici H, Celik AF. Characteristics, treatment, and long-term outcome of gastrointestinal involvement in Behcet’s syndrome: a strobe-compliant observational study from a dedicated multidisciplinary center. Medicine (Baltimore). 2016;95:e3348.

    Article  CAS  Google Scholar 

  83. Dilsen N, Konice M, Ovul C, editors. Clinical evaluation of 106 cases of Behçet’s disease. Behçet’s disease. Proceedings of an international symposium on Behçet’s disease. Amsterdam: Excerpta Medica; 1979. p. 124–9.

    Google Scholar 

  84. Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet’s disease. Int J Dermatol. 2003;42:346–51.

    Article  PubMed  Google Scholar 

  85. Al-Rawi ZS, Sharquie KE, Khalifa SJ, Al-Hadithi FM, Munir JJ. Behçet’s disease in Iraqi patients. Ann Rheum Dis. 1986;45:987–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Shahram F, Davatchi F, Nadji A, Jamshidi A, Chams H, Chams C, Shafaie N, Akbarian M, Gharibdoost F. Recent epidemiological data on Behçet’s disease in Iran: the 2001 survey. Adv Exp Med Biol. 2003;528:31–6.

    Article  CAS  PubMed  Google Scholar 

  87. Madanat W, Sharaiha Z, Khasawneh S, Zureikat H, Fayyad F. Gastro-intestinal manifestations of Behçet’s disease. Adv Exp Med Biol. 2003;528:455–7.

    Article  PubMed  Google Scholar 

  88. Hamdan A, Mansour W, Uthman I, Masri AF, Nasr F, Arayssi T. Behçet’s disease in Lebanon: clinical profile, severity and two-decade comparison. Clin Rheumatol. 2006;25:364–7.

    Article  PubMed  Google Scholar 

  89. Al-Dalaan A, al Balaa S, el Ramahi K, al-Kawi Z, Bohlega S, Bahabri S, et al. Behçet’s disease in Saudi Arabia. J Rheumatol. 1994;21:658–61.

    CAS  PubMed  Google Scholar 

  90. Ward EM, Woodward TA, Mazlumzadeh M, Calamia KT. Gastrointestinal disease in Behçet’s disease. Adv Exp Med Biol. 2003;528:459–64.

    Article  PubMed  Google Scholar 

  91. Yazici Y, Schimmel E, Swearingen CJ. Behçet’s syndrome in the US: clinical characteristics, treatment and ethnic/racial differences in manifestations in 347 patients with BS. Arthritis Rheum. 2009;60(Suppl).

    Google Scholar 

  92. Kobayashi T, Kishimoto M, Tokuda Y, Schimmel E, Swearingen C, Yoshida K, Utsunomiya M, Yamamoto M, Yazici Y. Disease manifestations and treatment differences among Behçet’s syndrome patients in the United States and Japan. Ann Rheum Dis. 2009;68(SIII):609.

    Google Scholar 

  93. Rodríguez-Carballeira M, Alba MA, Solans-Laqué R, et al. Registry of the Spanish network of Behçet’s disease: a descriptive analysis of 496 patients. Clin Exp Rheumatol. 2014;32(Suppl. 84):S33–9.

    PubMed  Google Scholar 

  94. Tuzun Y, Yazici H, Pazarli H, Yalcin B, Yurdakul S, Muftuoglu A. The usefulness of the nonspecific skin hyperreactivity (the pathergy test) in Behçet’s disease in Turkey. Acta Derm Venereol (Stockh). 1979;59:77–9.

    CAS  Google Scholar 

  95. Altac M, Tuzun Y, Yurdakul S, Binyildiz P, Yazici H. The validity of the pathergy test (non-specific skin hyperreactivity) in Behçet’s disease: a double blind study by independent observers. Acta Derm Venereol (Stockh). 1982;62:158–9.

    CAS  Google Scholar 

  96. Yazici H, Tuzun Y, Pazarli H, Yalcin B, Yurdakul S, Muftuoglu A. The combined use of HLA-B5 and pathergy test as diagnostic markers of Behçet’s disease in Turkey. J Rheumatol. 1980;7:206–10.

    CAS  PubMed  Google Scholar 

  97. Davies PG, Fordham JN, Kirwan JR, Barnes CG, Dinning WJ. The pathergy test and Behçet’s syndrome in Britain. Ann Rheum Dis. 1984;43:70–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Yazici H, Chamberlain MA, Tuzun Y, et al. A comparative study of the pathergy among Turkish and British patients with Behçet’s disease. Ann Rheum Dis. 1984;43:74–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Dilsen N, Konice M, Aral O, Ocal L, Inanc M, Gul A. Comparative study of the skin pathergy test with blunt and sharp needles in Behçet’s disease: confirmed specificity but decreased sensitivity with sharp needles. Ann Rheum Dis. 1993;52:823–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Ohno S, Aoki K, Sugiura S, Nakayama E, Itakura K, Aizawa M. HL-A5 and Behçet’s disease. Lancet. 1973;2:1383–4.

    Article  CAS  PubMed  Google Scholar 

  101. Ohno S, Asanuma T, Sugiura S, et al. HLA-Bw51 and Behçet’s disease. JAMA. 1978;240:529.

    Article  CAS  PubMed  Google Scholar 

  102. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behçet’s disease. Arch Ophthalmol. 1982;100:1455–8.

    Article  CAS  PubMed  Google Scholar 

  103. Gul A, Uyar FA, Inanc M, Ocal L, Barrett JH, Aral O, Konice M, Saruhan-Direskeneli G. A weak association of HLA-B∗2702 with Behçet’s disease. Genes Immun. 2002;3:368–72.

    Article  CAS  PubMed  Google Scholar 

  104. Chang HK, Kim JW. The clinical features of Behçet’s disease in Yongdong districts: analysis of a cohort followed from 1997 to 2001. J Korean Med Sci. 2002;17:784–9.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Lennikov A, Alekberova Z, Goloeva R, Kitaichi N, Denisov L, Namba K, et al. Single center study on ethnic and clinical features of Behcet’s disease in Moscow, Russia. Clin Rheumatol. 2015;34:321–7.

    Article  PubMed  Google Scholar 

  106. O’Duffy JD, Taswell HF, Elveback LR. HLA antigens in Behçet’s disease. J Rheumatol. 1974;3:1.

    Google Scholar 

  107. Moore SB, O’Duffy JD. Lack of association between Behçet’s disease and major histocompatibility complex II antigens in an ethnically diverse North American Caucasoid patient group. J Rheumatol. 1986;13:771–3.

    CAS  PubMed  Google Scholar 

  108. Lewis KA, Graham EM, Stanford MR. Systematic review of ethnic variation in the phenotype of Behçet’s disease. Scand J Rheumatol. 2007;36:1–6.

    Article  CAS  PubMed  Google Scholar 

  109. Kotake S, Namba K, Higashi K, Goda C, Ariga T, Ogawa A, Ohno S. The change of clinical manifestations of patients with Behçet’s disease in Japan. Adv Exp Med Biol. 2003;528:83–4.

    Article  PubMed  Google Scholar 

  110. Yoshida A, Kawashima H, Motoyama Y, Shibui H, Kaburaki T, Shimizu K, et al. Comparison of patients with Behçet’s disease in the 1980s and 1990s. Ophthalmology. 2004;111:810–5.

    Article  PubMed  Google Scholar 

  111. Bang D, Oh S, Lee K-H, Lee E-S, Lee S. Influence of sex on patients with Behçet’s disease in Korea. J Korean Med Sci. 2003;18:231–5.

    Article  PubMed  PubMed Central  Google Scholar 

  112. Wang LY, Zhao DB, Gu J, Dai SM. Clinical characteristics of Behçet’s disease in China. Rheumatol Int. 2010;30:1191–6.

    Article  CAS  PubMed  Google Scholar 

  113. Zhang Z, He F, Shi Y. Behçet’s disease seen in China: analysis of 334 cases. Rheumatol Int. 2013;33:645–8.

    Article  CAS  PubMed  Google Scholar 

  114. Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y. Behçet disease: evolution of clinical manifestations. Medicine (Baltimore). 2011;90:125–32.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey

    Sebahattin Yurdakul

Authors
  1. Sebahattin Yurdakul
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Medicine, New York University, New York, NY, USA

    Yusuf Yazici

  2. Department of Internal Medicine, Istanbul University, Istanbul, Turkey

    Gulen Hatemi

  3. Department of Rheumatology, Istanbul University, Istanbul, Turkey

    Emire Seyahi

  4. Department of Medicine, Academic Hospital, Istanbul, Turkey

    Hasan Yazici

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yurdakul, S. (2020). Epidemiology of Behçet Syndrome and Regional Differences in Disease Expression. In: Yazici, Y., Hatemi, G., Seyahi, E., Yazici, H. (eds) Behçet Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-030-24131-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-24131-5_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-24130-8

  • Online ISBN: 978-3-030-24131-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation